Rol de la microbiota intestinal en el desarrollo del hígado graso no alcohólico

par Tumani,María Fernanda, Tapia,Gladys, Aguirre,Carolina, Obregón,Ana María, Pettinelli,Paulina
Publié 2021

Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica

par Lanuza,Fabian, Sapunar,Jorge, Hofmann,Edmundo
Publié 2018

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice

par Cosmas Rinaldi Adithya Lesmana, Mutiara Lirendra, Laurentius Adrianto Lesmana
Publié 2019

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies

par Tetiana Ranhulova
Publié 2021

What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review

par Mar Talens, Natalia Tumas, Jeffrey V. Lazarus, Joan Benach, Juan M. Pericàs
Publié 2021

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study

par Rayvita AN Meagratia, Ferdy Kurniawan Cayami, Udin Bahrudin, Wiwik Lestari, Nani Maharani, Sultana MH Faradz, Hery Djagat Purnomo
Publié 2021

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies

par Aleksandr E. Nosov, Mariia T. Zenina, Olga Y. Gorbushina, Anastasiia S. Baidina, Elena M. Vlasova, Vadim B. Alekseev
Publié 2021

Cytoprotective and suicidal signaling in oxidative stress

par Videla,Luis A
Publié 2010

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets

par Daniela Maria Tanase, Evelina Maria Gosav, Daniela Petrov, Alina Ecaterina Jucan, Cristina Mihaela Lacatusu, Mariana Floria, Claudia Cristina Tarniceriu, Claudia Florida Costea, Manuela Ciocoiu, Ciprian Rezus
Publié 2021

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease

par Szanto KB, Li J, Cordero P, Oben JA
Publié 2019

Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial

par Fatemeh Naeini, Zahra Namkhah, Helda Tutunchi, Seyed Mahdi Rezayat, Siavash Mansouri, Seyed Ali Jazayeri-Tehrani, Mehdi Yaseri, Mohammad Javad Hosseinzadeh-Attar
Publié 2021

Current concepts of the pathogenesis of non-alcoholic fatty liver disease

par Evgenia Pavlovna Kosobyan, Olga Mikhailovna Smirnova
Publié 2010

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

par Satoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, Yasunori Minami, Yoriaki Komeda, Tomoko Aoki, Masahiro Takita, Masahiro Morita, Hirokazu Chishina, Akihiro Yoshida, Hiroshi Ida, Masatoshi Kudo
Publié 2021

High-Normal Serum Thyrotropin Levels Increased the Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects with Type 2 Diabetes

par Tan Y, Tang X, Mu P, Yang Y, Li M, Nie Y, Li H, Zhu Y, Chen Y
Publié 2021

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study

par Zhi-Qin Xie, Hong-Xia Li, Wen-Liang Tan, Lei Yang, Xiao-Wu Ma, Wen-Xin Li, Qing-Bin Wang, Chang-Zhen Shang, Ya-Jin Chen
Publié 2021

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT

par Ana Šinkovec, Milanka Živanović, Martin Thaler, Jernej Brecelj
Publié 2021

Editorial: New Insights Into Understanding and Managing NAFLD

par Óscar Escribano, Daniel E. Francés, Yolanda F. Otero, Javier Egea, Águeda González-Rodríguez, Águeda González-Rodríguez
Publié 2021

PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS OF UNCONTROLLED AND CONTROLLED TYPE 2 DIABETES MELLITUS

par Aqeela Rashid, Sana Zafar, Aamir Bashir, Khush Bakht, Aman Ullah Bhalli
Publié 2019

Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population

par Magda Shaheen, Katrina M. Schrode, Deyu Pan, Dulcie Kermah, Vishwajeet Puri, Ali Zarrinpar, David Elisha, Sonia M. Najjar, Theodore C. Friedman
Publié 2021

Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study

par Sepehrimanesh M, Niknam R, Ejtehadi F, Fattahi MR, Safarpour A
Publié 2020